AZGP1 and metabolic dysfunction-associated steatotic liver disease: Recently, ZAG overexpression was shown to upregulate adiponectin and lipolysis genes, while downregulating fat synthesis genes, thus preventing NAFLD by alleviating hepatic steatosis, insulin resistance, and inflammation (Xiao et al., 2018).